<p>Teladoc Health（紐約證券交易所代碼：TDOC - 獲取免費報告）在週五發佈的研究報告中，花旗將其目標價格從 11.00 美元下調至 8.75 美元，Benzinga 報道。該公司目前對這家健康服務提供商的股票給予 “中性” 評級。花旗的目標價格意味着與該公司之前收盤價相比，潛在上漲幅度為 21.61%。</p>
<p>獲取 <strong>Teladoc Health</strong> 警報：</p>
<ul>
<li>2 只可能受益於特朗普新任 FDA 官員的遠程醫療股票</li>
</ul>
<p>TDOC 曾是幾份其他研究報告的主題。Oppenheimer 將 Teladoc Health 的目標價格從 14.00 美元下調至 12.00 美元，並在 1 月 24 日的研究報告中給予該公司 “跑贏大盤” 的評級。高盛將 Teladoc Health 的目標價格從 16.00 美元下調至 13.00 美元，並在 3 月 3 日的研究報告中給予該股票 “買入” 評級。加拿大皇家銀行將 Teladoc Health 的目標價格從 11.00 美元上調至 12.00 美元，並在 1 月 24 日的研究報告中給予該公司 “跑贏大盤” 的評級。Jefferies Financial Group 在週一的研究報告中將 Teladoc Health 的目標價格從 10.00 美元下調至 8.00 美元，並對該股票給予 “持有” 評級。最後，Needham &amp; Company LLC 在 2 月 27 日的研究報告中重申了對 Teladoc Health 股票的 “持有” 評級。十二位分析師對該股票給予了持有評級，七位分析師給予了買入評級。根據 MarketBeat 的數據，該公司目前的平均評級為 “持有”，平均目標價格為 10.71 美元。</p>
<p><strong>查看我們最新的 TDOC 股票報告</strong></p>
<h2>Teladoc Health 股票下跌 0.9%</h2>
<ul>
<li>2 只曾經的疫情明星股票瞄準 2025 年的大反彈</li>
</ul>
<p>在週五的午盤交易中，Teladoc Health 股票下跌 0.07 美元，達到 7.20 美元。該公司的股票交易量為 466,899 股，而其平均交易量為 6,220,314 股。該公司的 50 日簡單移動平均線為 8.63 美元，200 日簡單移動平均線為 9.58 美元。該公司的市值為 12.6 億美元，市盈率為-1.25，貝塔值為 1.73。Teladoc Health 的 52 周低點為 6.35 美元，52 周高點為 15.21 美元。該公司的速動比率為 1.69，流動比率為 1.73，債務與股本比率為 0.66。</p>
<p>Teladoc Health（紐約證券交易所代碼：TDOC - 獲取免費報告）最後一次公佈季度財報是在 2 月 26 日。該健康服務提供商報告的每股收益（EPS）為-0.28 美元，低於分析師一致預期的-0.21 美元，差距為 0.07 美元。Teladoc Health 的淨利潤率為-37.91%，股本回報率為-10.06%。該公司在本季度的收入為 6.4049 億美元，而分析師預期為 6.3944 億美元。研究分析師預計 Teladoc Health 在當前財政年度的每股收益將為-1.16 美元。</p>
<h2>Teladoc Health 的內部活動</h2>
<ul>
<li>Doximity：‘醫生的 Facebook’ 在財報超預期後大幅上漲</li>
</ul>
<p>在相關消息中，內部人士 Adam C. Vandervoort 在 3 月 20 日的交易中出售了 11,011 股該股票。股票以平均價格 8.42 美元出售，總價值為 92,712.62 美元。出售後，該內部人士現在直接持有 64,308 股公司股票，價值約為 541,473.36 美元。這代表其持股減少了 14.62%。該出售在與證券交易委員會的法律文件中披露，文件可在此鏈接查看。公司內部人士目前持有該股票的 0.58%。</p>
<h2>Teladoc Health 的機構交易</h2>
<p>幾家大型投資者最近調整了對 TDOC 的持股。Golden State Wealth Management LLC 在第一季度將其在 Teladoc Health 的持股增加了 102.6%。Golden State Wealth Management LLC 現在擁有 3,337 股該健康服務提供商的股票，價值 27,000 美元，此前在上個季度又購買了 1,690 股。Versant Capital Management Inc 在第四季度將其在 Teladoc Health 的持股增加了 313.8%。Versant Capital Management Inc 現在擁有 3,219 股該健康服務提供商的股票，價值 29,000 美元，此前在上個季度又收購了 2,441 股。Whipplewood Advisors LLC 在第四季度購買了 Teladoc Health 的新股份，價值約為 29,000 美元。Lindbrook Capital LLC 在第四季度將其在 Teladoc Health 的持股增加了 78.9%。Lindbrook Capital LLC 現在擁有 3,654 股該健康服務提供商的股票，價值 33,000 美元，此前在上個季度又購買了 1,612 股。最後，Sterling Capital Management LLC 在第四季度將其在 Teladoc Health 的持股增加了 776.7%。Sterling Capital Management LLC 現在擁有 4,629 股該健康服務提供商的股票，價值 42,000 美元，此前在上個季度又購買了 4,101 股。目前 76.82% 的股票由機構投資者和對沖基金持有。</p>
<h2>關於 Teladoc Health</h2>
<p>（獲取免費報告）</p>
<p>Teladoc Health, Inc 在全球提供虛擬醫療服務。該公司通過 Teladoc Health 綜合護理和 BetterHelp 兩個部門運營。綜合護理部門提供虛擬醫療服務，包括普通醫療、專家醫療、專科醫療、慢性病管理和心理健康，以及為醫院和健康系統提供的技術和企業遠程醫療解決方案。</p>
<h2>另請參閲</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Teladoc Health</li>
<li>股息篩選器：如何在購買前評估股息股票</li>
<li>空頭最近放棄了這 3 只股票</li>
<li>除了喝咖啡，還有 3 種投資咖啡的方法</li>
<li>3 只表現優於市場的無聊股票</li>
<li>內部交易 - 你需要知道的事項</li>
<li>如果你想購買 AbbVie 卻沒有，現在仍然有機會購買</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRET0M?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRET0M"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1000 美元在 Teladoc Health 嗎？</h2>
<p>在考慮 Teladoc Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Teladoc Health 並不在名單上。</p>
<p>雖然 Teladoc Health 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

TDOC

<p>花旗集團已將 Teladoc Health（紐約證券交易所代碼：TDOC）的目標股價從 11.00 美元下調至 8.75 美元，維持 “中性” 評級。這一調整表明與前一交易日收盤價相比，潛在上漲幅度為 21.61%。其他分析師也調整了他們的目標價，Oppenheimer 將其設定為 12.00 美元，高盛則為 13.00 美元。目前，Teladoc 的股票交易價格為 7.20 美元，下跌 0.9%，平均評級為 “持有”，來自十二位分析師的目標價為 10.71 美元。該公司在上個季度報告的每股虧損為 0.28 美元，未能達到預期</p>

<p>Teladoc Health (NYSE:TDOC - Get Free Report) had its price objective cut by Citigroup from $11.00 to $8.75 in a research report issued on Friday,Benzinga reports. The firm presently has a &#34;neutral&#34; rating on the health services provider's stock. Citigroup's price objective would indicate a potential upside of 21.61% from the company's previous close.</p>
<div class="lb-trans"><p>Teladoc Health（紐約證券交易所代碼：TDOC - 獲取免費報告）在週五發佈的研究報告中，花旗將其目標價格從 11.00 美元下調至 8.75 美元，Benzinga 報道。該公司目前對這家健康服務提供商的股票給予 “中性” 評級。花旗的目標價格意味着與該公司之前收盤價相比，潛在上漲幅度為 21.61%。</p>
</div><p>Get <strong>Teladoc Health</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Teladoc Health</strong> 警報：</p>
</div><ul>
<li>2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只可能受益於特朗普新任 FDA 官員的遠程醫療股票</li>
</ul>
</div><p>TDOC has been the subject of several other research reports. Oppenheimer decreased their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an &#34;outperform&#34; rating for the company in a research note on Friday, January 24th. The Goldman Sachs Group dropped their price target on Teladoc Health from $16.00 to $13.00 and set a &#34;buy&#34; rating on the stock in a research note on Monday, March 3rd. Royal Bank of Canada boosted their price objective on Teladoc Health from $11.00 to $12.00 and gave the company an &#34;outperform&#34; rating in a research note on Friday, January 24th. Jefferies Financial Group lowered their target price on shares of Teladoc Health from $10.00 to $8.00 and set a &#34;hold&#34; rating on the stock in a research report on Monday. Finally, Needham &amp; Company LLC reiterated a &#34;hold&#34; rating on shares of Teladoc Health in a research report on Thursday, February 27th. Twelve analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of &#34;Hold&#34; and an average price target of $10.71.</p>
<div class="lb-trans"><p>TDOC 曾是幾份其他研究報告的主題。Oppenheimer 將 Teladoc Health 的目標價格從 14.00 美元下調至 12.00 美元，並在 1 月 24 日的研究報告中給予該公司 “跑贏大盤” 的評級。高盛將 Teladoc Health 的目標價格從 16.00 美元下調至 13.00 美元，並在 3 月 3 日的研究報告中給予該股票 “買入” 評級。加拿大皇家銀行將 Teladoc Health 的目標價格從 11.00 美元上調至 12.00 美元，並在 1 月 24 日的研究報告中給予該公司 “跑贏大盤” 的評級。Jefferies Financial Group 在週一的研究報告中將 Teladoc Health 的目標價格從 10.00 美元下調至 8.00 美元，並對該股票給予 “持有” 評級。最後，Needham &amp; Company LLC 在 2 月 27 日的研究報告中重申了對 Teladoc Health 股票的 “持有” 評級。十二位分析師對該股票給予了持有評級，七位分析師給予了買入評級。根據 MarketBeat 的數據，該公司目前的平均評級為 “持有”，平均目標價格為 10.71 美元。</p>
</div><p><strong>View Our Latest Stock Report on TDOC</strong></p>
<div class="lb-trans"><p><strong>查看我們最新的 TDOC 股票報告</strong></p>
</div><h2>Teladoc Health Stock Down 0.9 %</h2>
<div class="lb-trans"><h2>Teladoc Health 股票下跌 0.9%</h2>
</div><ul>
<li>2 Former Pandemic Darlings Eyeing a Big 2025 Turnaround</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只曾經的疫情明星股票瞄準 2025 年的大反彈</li>
</ul>
</div><p>Teladoc Health stock traded down $0.07 during midday trading on Friday, reaching $7.20. The company's stock had a trading volume of 466,899 shares, compared to its average volume of 6,220,314. The business has a 50-day simple moving average of $8.63 and a 200-day simple moving average of $9.58. The company has a market cap of $1.26 billion, a P/E ratio of -1.25 and a beta of 1.73. Teladoc Health has a fifty-two week low of $6.35 and a fifty-two week high of $15.21. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.</p>
<div class="lb-trans"><p>在週五的午盤交易中，Teladoc Health 股票下跌 0.07 美元，達到 7.20 美元。該公司的股票交易量為 466,899 股，而其平均交易量為 6,220,314 股。該公司的 50 日簡單移動平均線為 8.63 美元，200 日簡單移動平均線為 9.58 美元。該公司的市值為 12.6 億美元，市盈率為-1.25，貝塔值為 1.73。Teladoc Health 的 52 周低點為 6.35 美元，52 周高點為 15.21 美元。該公司的速動比率為 1.69，流動比率為 1.73，債務與股本比率為 0.66。</p>
</div><p>Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. On average, research analysts expect that Teladoc Health will post -1.16 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Teladoc Health（紐約證券交易所代碼：TDOC - 獲取免費報告）最後一次公佈季度財報是在 2 月 26 日。該健康服務提供商報告的每股收益（EPS）為-0.28 美元，低於分析師一致預期的-0.21 美元，差距為 0.07 美元。Teladoc Health 的淨利潤率為-37.91%，股本回報率為-10.06%。該公司在本季度的收入為 6.4049 億美元，而分析師預期為 6.3944 億美元。研究分析師預計 Teladoc Health 在當前財政年度的每股收益將為-1.16 美元。</p>
</div><h2>Insider Activity at Teladoc Health</h2>
<div class="lb-trans"><h2>Teladoc Health 的內部活動</h2>
</div><ul>
<li>Doximity: The 'Facebook for Doctors' Surges After Earnings Beat</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity：‘醫生的 Facebook’ 在財報超預期後大幅上漲</li>
</ul>
</div><p>In related news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the sale, the insider now directly owns 64,308 shares of the company's stock, valued at approximately $541,473.36. This represents a 14.62 % decrease in their position. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available at this hyperlink. 0.58% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在相關消息中，內部人士 Adam C. Vandervoort 在 3 月 20 日的交易中出售了 11,011 股該股票。股票以平均價格 8.42 美元出售，總價值為 92,712.62 美元。出售後，該內部人士現在直接持有 64,308 股公司股票，價值約為 541,473.36 美元。這代表其持股減少了 14.62%。該出售在與證券交易委員會的法律文件中披露，文件可在此鏈接查看。公司內部人士目前持有該股票的 0.58%。</p>
</div><h2>Institutional Trading of Teladoc Health</h2>
<div class="lb-trans"><h2>Teladoc Health 的機構交易</h2>
</div><p>Several large investors have recently modified their holdings of TDOC. Golden State Wealth Management LLC lifted its stake in Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after buying an additional 1,690 shares in the last quarter. Versant Capital Management Inc boosted its stake in shares of Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock valued at $29,000 after acquiring an additional 2,441 shares during the last quarter. Whipplewood Advisors LLC purchased a new stake in Teladoc Health during the 4th quarter worth about $29,000. Lindbrook Capital LLC raised its stake in Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after purchasing an additional 1,612 shares during the last quarter. Finally, Sterling Capital Management LLC lifted its holdings in Teladoc Health by 776.7% in the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after purchasing an additional 4,101 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>幾家大型投資者最近調整了對 TDOC 的持股。Golden State Wealth Management LLC 在第一季度將其在 Teladoc Health 的持股增加了 102.6%。Golden State Wealth Management LLC 現在擁有 3,337 股該健康服務提供商的股票，價值 27,000 美元，此前在上個季度又購買了 1,690 股。Versant Capital Management Inc 在第四季度將其在 Teladoc Health 的持股增加了 313.8%。Versant Capital Management Inc 現在擁有 3,219 股該健康服務提供商的股票，價值 29,000 美元，此前在上個季度又收購了 2,441 股。Whipplewood Advisors LLC 在第四季度購買了 Teladoc Health 的新股份，價值約為 29,000 美元。Lindbrook Capital LLC 在第四季度將其在 Teladoc Health 的持股增加了 78.9%。Lindbrook Capital LLC 現在擁有 3,654 股該健康服務提供商的股票，價值 33,000 美元，此前在上個季度又購買了 1,612 股。最後，Sterling Capital Management LLC 在第四季度將其在 Teladoc Health 的持股增加了 776.7%。Sterling Capital Management LLC 現在擁有 4,629 股該健康服務提供商的股票，價值 42,000 美元，此前在上個季度又購買了 4,101 股。目前 76.82% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>About Teladoc Health</h2>
<div class="lb-trans"><h2>關於 Teladoc Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.</p>
<div class="lb-trans"><p>Teladoc Health, Inc 在全球提供虛擬醫療服務。該公司通過 Teladoc Health 綜合護理和 BetterHelp 兩個部門運營。綜合護理部門提供虛擬醫療服務，包括普通醫療、專家醫療、專科醫療、慢性病管理和心理健康，以及為醫院和健康系統提供的技術和企業遠程醫療解決方案。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另請參閲</h2>
</div><ul>
<li>Five stocks we like better than Teladoc Health</li>
<li>Dividend Screener: How to Evaluate Dividend Stocks Before Buying</li>
<li>Short Sellers Gave Up on These 3 Names Recently</li>
<li>3 Ways To Invest In Coffee, Other Than Drinking It</li>
<li>3 Boring Stocks Outperforming the Market This Year</li>
<li>Insider Trading - What You Need to Know</li>
<li>If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Teladoc Health</li>
<li>股息篩選器：如何在購買前評估股息股票</li>
<li>空頭最近放棄了這 3 只股票</li>
<li>除了喝咖啡，還有 3 種投資咖啡的方法</li>
<li>3 只表現優於市場的無聊股票</li>
<li>內部交易 - 你需要知道的事項</li>
<li>如果你想購買 AbbVie 卻沒有，現在仍然有機會購買</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRET0M" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=TDOC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Teladoc Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Teladoc Health 嗎？</h2>
</div><p>Before you consider Teladoc Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Teladoc Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Teladoc Health 並不在名單上。</p>
</div><p>While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Teladoc Health 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Citigroup Cuts Teladoc Health (NYSE:TDOC) Price Target to $8.75

花旗集團將 Teladoc Health（NYSE:TDOC）的目標股價下調至 8.75 美元